Learn more about our Advocacy work.
The House Ways and Means Committee voted to pass the bipartisan H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act, during a markup meeting.
AdvaMed® released a statement in support of the bipartisan PREVENT DIABETES Act, which was marked up today in the House Energy and Commerce Health Subcommittee. The legislation, introduced by Reps. Diana…
Today, AdvaMed, The Medtech Association®, and Consumer Technology Association (CTA)® hosted a Congressional Digital Health Caucus briefing on remote patient monitoring (RPM) in coordination with Caucus co-chairs Rep. Troy Balderson…
This week, AdvaMed, The Medtech Association®, responded to a request for information from Congressman Ami Bera regarding the use of artificial intelligence (AI) in health care.
This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed® President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses…
Today, Zach Rothstein, Executive Director of AdvaMedDx®, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed…
Former U.S. Senator Richard Burr of North Carolina joined me on the Medtech POV podcast to share his perspective on policy and leadership. Having served in the U.S. House and…
Scott Whitaker, President and CEO of AdvaMed, The Medtech Association®, sent a letter to CMS Administrator Chiquita Brooks-LaSure outlining industry disappointment in the lack of a finalized rule for Transitional…
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
Today, AdvaMed, The Medtech Association®, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.